InsidersTradesSigma
Track the Sai Life Sciences Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Sai Life Sciences Limited has logged 1 public disclosures. Market capitalisation: €279.2bn. The latest transaction was disclosed on 21 February 2025 (Sale). Among the most active insiders: TUNER GHOSH. All data is accessible without an account.
Analysts rate Sai Life Sciences Limited Strong Buy (bullish), based on 6 analysts. Average price target: ₹1,275.00.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Sai Life Sciences Limited是一家专注于医疗保健和制药领域的公司，提供研发解决方案和制造服务。它在孟买证券交易所上市。